These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34159427)

  • 41. The influence of polymeric subcoats and pellet formulation on the release of chlorpheniramine maleate from enteric coated pellets.
    Bruce LD; Koleng JJ; McGinity JW
    Drug Dev Ind Pharm; 2003 Sep; 29(8):909-24. PubMed ID: 14570312
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Dissolution of omeprazole from delayed-release solid oral dosage forms.
    Farinha A; Bica A; Martins JM; Pais JP
    Drug Dev Ind Pharm; 2000 Jul; 26(7):785-90. PubMed ID: 10872100
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mucoadhesive platforms for targeted delivery to the colon.
    Varum FJ; Veiga F; Sousa JS; Basit AW
    Int J Pharm; 2011 Nov; 420(1):11-9. PubMed ID: 21856393
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Measuring dissolution profiles of single controlled-release drug pellets.
    Bhakta HC; Lin JM; Grover WH
    Sci Rep; 2020 Nov; 10(1):19734. PubMed ID: 33184351
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Preparation and in vitro/in vivo evaluation of esomeprazole magnesium-modified release pellets.
    Kan SL; Lu J; Liu JP; Zhao Y
    Drug Deliv; 2016; 23(3):866-73. PubMed ID: 24892629
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of in-vitro dissolution and in-vivo absorption for two different film-coated pellets of clarithromycin.
    Zhang XR; Chen XY; Hu LD; Tang X; Li SM; Zhong DF
    Arch Pharm Res; 2005 Aug; 28(8):977-82. PubMed ID: 16178426
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A Review on Enteric Coated Pellets Composed of Core Pellets Prepared by Extrusion-Spheronization.
    Patel H; Gohel M
    Recent Pat Drug Deliv Formul; 2019; 13(2):83-90. PubMed ID: 30747090
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Preparation, Characterization and Pharmacokinetics Evaluation of the Compound Capsules of Ibuprofen Enteric-Coated Sustained-Release Pellets and Codeine Phosphate Immediate-Release Pellets.
    Dong L; Yang F; Zhu Z; Yang Y; Zhang X; Ye M; Pan W; Pan H
    AAPS PharmSciTech; 2018 Oct; 19(7):3057-3066. PubMed ID: 30091062
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In vitro study on capsule formulations of omeprazole containing enteric coated granules.
    Pandey VP; Phanindrudu A; Manavalan R; Livingston J
    Boll Chim Farm; 2002; 141(6):419-22. PubMed ID: 12577509
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relative bioavailability and pharmacokinetic study of omeprazole 20 mg enteric-coated tablet in healthy Bangladeshi volunteers.
    Hasan A; Abul Kalam Azad M; Ullah MA; Mahbub Latif AH; Hasnat A
    Int J Clin Pharmacol Ther; 2009 Mar; 47(3):215-21. PubMed ID: 19281731
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Sustained-release pellets prepared by combination of wax matrices and double-layer coatings for extremely water-soluble drugs.
    Tian L; Zhang Y; Tang X
    Drug Dev Ind Pharm; 2008 Jun; 34(6):569-76. PubMed ID: 18568906
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Omeprazole impairs the absorption of mycophenolate mofetil but not of enteric-coated mycophenolate sodium in healthy volunteers.
    Kees MG; Steinke T; Moritz S; Rupprecht K; Paulus EM; Kees F; Bucher M; Faerber L
    J Clin Pharmacol; 2012 Aug; 52(8):1265-72. PubMed ID: 21903891
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Blends of enteric and GIT-insoluble polymers used for film coating: physicochemical characterization and drug release patterns.
    Lecomte F; Siepmann J; Walther M; MacRae RJ; Bodmeier R
    J Control Release; 2003 May; 89(3):457-71. PubMed ID: 12737848
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gastro-resistant characteristics of GRAS-grade enteric coatings for pharmaceutical and nutraceutical products.
    Czarnocka JK; Alhnan MA
    Int J Pharm; 2015; 486(1-2):167-74. PubMed ID: 25796126
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of acid secretory status on absorption of omeprazole from enteric coated granules.
    Andersson T; Bergstrand R; Cederberg C
    Br J Clin Pharmacol; 1991 Mar; 31(3):275-8. PubMed ID: 2054268
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Factors Contributing to Drug Release From Enteric-Coated Omeprazole Capsules: An In Vitro and In Vivo Pharmacokinetic Study and IVIVC Evaluation in Beagle Dogs.
    Cui C; Sun J; Wang X; Yu Z; Shi Y
    Dose Response; 2020; 18(1):1559325820908980. PubMed ID: 32180688
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An in vitro/in vivo correlation for the disintegration and onset of drug release from enteric-coated pellets.
    Ebel JP; Jay M; Beihn RM
    Pharm Res; 1993 Feb; 10(2):233-8. PubMed ID: 8456070
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evaluation of the USP dissolution test method A for enteric-coated articles by planar laser-induced fluorescence.
    Miller DA; Gamba M; Sauer D; Purvis TP; Clemens NT; Williams RO
    Int J Pharm; 2007 Feb; 330(1-2):61-72. PubMed ID: 17034967
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stability of capsules containing omeprazole in enteric coated pellets.
    Palummo M; Cingolani A; Dall L; Volonté MG
    Boll Chim Farm; 2000; 139(3):124-8. PubMed ID: 10961022
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Compression of pellets coated with various aqueous polymer dispersions.
    Dashevsky A; Kolter K; Bodmeier R
    Int J Pharm; 2004 Jul; 279(1-2):19-26. PubMed ID: 15234790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.